Review



hct116 brca2  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC hct116 brca2
    Hct116 Brca2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 19345 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hct116 brca2/product/ATCC
    Average 99 stars, based on 19345 article reviews
    hct116 brca2 - by Bioz Stars, 2026-03
    99/100 stars

    Images



    Similar Products

    99
    ATCC hct116 brca2
    Hct116 Brca2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hct116 brca2/product/ATCC
    Average 99 stars, based on 1 article reviews
    hct116 brca2 - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    90
    Johns Hopkins HealthCare hct116 brca2 -/- cells
    Antitumoral efficacy of NDI-NIs in advanced 3D models. Advanced 3D spheroids were established from human colorectal cancer cells <t>(HCT116)</t> by growing the cells within drops of a methylcellulose scaffold matrix (day 0). After 2 days of culture (day 2), the spheres were treated with the indicated compound at final concentrations of 1, 2, and 5 μM. ( A ) Time course analysis of tumor spheroids growth, starting from 24 h after treatment (day 3), monitored by Incucyte ® S3 Live-Cell Analysis System (Essen BioScience, Ann Arbor, MI), 10× magnification. The results were expressed as the percentage of the spheroids area upon treatment relative to their own area before the compound administration. The histogram represents the mean values ± S.E.M. of at least four spheres. ( B ) Representative images of tumor spheroids growth described in panel (A). ( C ) Histological and immunohistochemical analysis of the spheroids generated from HCT116 cell lines and grown as in panel (A). Upper panels , representative images of immunostained sections. Lower panels, quantification of Ki-67, cleaved-caspase and γH2AX levels, expressed as percentage of positive cells. Thirty fields for condition were analyzed. The histograms represent the mean values ± S.D. of three independent experiments. * P < .05, ** P < .01, *** P < .001, and **** P < .0001.
    Hct116 Brca2 / Cells, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hct116 brca2 -/- cells/product/Johns Hopkins HealthCare
    Average 90 stars, based on 1 article reviews
    hct116 brca2 -/- cells - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Charles River Laboratories hct116 brca2−/− cell-derived xenografts
    Antitumoral efficacy of NDI-NIs in advanced 3D models. Advanced 3D spheroids were established from human colorectal cancer cells <t>(HCT116)</t> by growing the cells within drops of a methylcellulose scaffold matrix (day 0). After 2 days of culture (day 2), the spheres were treated with the indicated compound at final concentrations of 1, 2, and 5 μM. ( A ) Time course analysis of tumor spheroids growth, starting from 24 h after treatment (day 3), monitored by Incucyte ® S3 Live-Cell Analysis System (Essen BioScience, Ann Arbor, MI), 10× magnification. The results were expressed as the percentage of the spheroids area upon treatment relative to their own area before the compound administration. The histogram represents the mean values ± S.E.M. of at least four spheres. ( B ) Representative images of tumor spheroids growth described in panel (A). ( C ) Histological and immunohistochemical analysis of the spheroids generated from HCT116 cell lines and grown as in panel (A). Upper panels , representative images of immunostained sections. Lower panels, quantification of Ki-67, cleaved-caspase and γH2AX levels, expressed as percentage of positive cells. Thirty fields for condition were analyzed. The histograms represent the mean values ± S.D. of three independent experiments. * P < .05, ** P < .01, *** P < .001, and **** P < .0001.
    Hct116 Brca2−/− Cell Derived Xenografts, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hct116 brca2−/− cell-derived xenografts/product/Charles River Laboratories
    Average 90 stars, based on 1 article reviews
    hct116 brca2−/− cell-derived xenografts - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    99
    ATCC cell lines hct116 brca2
    Table 1
    Cell Lines Hct116 Brca2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cell lines hct116 brca2/product/ATCC
    Average 99 stars, based on 1 article reviews
    cell lines hct116 brca2 - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    Image Search Results


    Antitumoral efficacy of NDI-NIs in advanced 3D models. Advanced 3D spheroids were established from human colorectal cancer cells (HCT116) by growing the cells within drops of a methylcellulose scaffold matrix (day 0). After 2 days of culture (day 2), the spheres were treated with the indicated compound at final concentrations of 1, 2, and 5 μM. ( A ) Time course analysis of tumor spheroids growth, starting from 24 h after treatment (day 3), monitored by Incucyte ® S3 Live-Cell Analysis System (Essen BioScience, Ann Arbor, MI), 10× magnification. The results were expressed as the percentage of the spheroids area upon treatment relative to their own area before the compound administration. The histogram represents the mean values ± S.E.M. of at least four spheres. ( B ) Representative images of tumor spheroids growth described in panel (A). ( C ) Histological and immunohistochemical analysis of the spheroids generated from HCT116 cell lines and grown as in panel (A). Upper panels , representative images of immunostained sections. Lower panels, quantification of Ki-67, cleaved-caspase and γH2AX levels, expressed as percentage of positive cells. Thirty fields for condition were analyzed. The histograms represent the mean values ± S.D. of three independent experiments. * P < .05, ** P < .01, *** P < .001, and **** P < .0001.

    Journal: Nucleic Acids Research

    Article Title: Naphthalene diimide-naphthalimide dyads promote telomere damage by selectively targeting multimeric G-quadruplexes

    doi: 10.1093/nar/gkaf301

    Figure Lengend Snippet: Antitumoral efficacy of NDI-NIs in advanced 3D models. Advanced 3D spheroids were established from human colorectal cancer cells (HCT116) by growing the cells within drops of a methylcellulose scaffold matrix (day 0). After 2 days of culture (day 2), the spheres were treated with the indicated compound at final concentrations of 1, 2, and 5 μM. ( A ) Time course analysis of tumor spheroids growth, starting from 24 h after treatment (day 3), monitored by Incucyte ® S3 Live-Cell Analysis System (Essen BioScience, Ann Arbor, MI), 10× magnification. The results were expressed as the percentage of the spheroids area upon treatment relative to their own area before the compound administration. The histogram represents the mean values ± S.E.M. of at least four spheres. ( B ) Representative images of tumor spheroids growth described in panel (A). ( C ) Histological and immunohistochemical analysis of the spheroids generated from HCT116 cell lines and grown as in panel (A). Upper panels , representative images of immunostained sections. Lower panels, quantification of Ki-67, cleaved-caspase and γH2AX levels, expressed as percentage of positive cells. Thirty fields for condition were analyzed. The histograms represent the mean values ± S.D. of three independent experiments. * P < .05, ** P < .01, *** P < .001, and **** P < .0001.

    Article Snippet: HCT116 TP53 -/- were obtained by Dr Vogelstein, Johns Hopkins University, and HCT116 BRCA2 -/- were kindly gifted from Dr Madalena Tarsounas.

    Techniques: Cell Analysis, Immunohistochemical staining, Generated

    Table 1

    Journal: The Journal of pathology

    Article Title: Up-regulation of the interferon-related genes in BRCA2 knockout epithelial cells

    doi: 10.1002/path.4404

    Figure Lengend Snippet: Table 1

    Article Snippet: Cell lines HCT116 BRCA2 +/+ cells were from ATCC (CCL-247), and the BRCA2 −/− cells were created in this study.

    Techniques: